DSM-Firmenich AG - Company Profile
Powered by
All the data and insights you need on DSM-Firmenich AG in one report.
- Save hours of research time and resources with
our up-to-date DSM-Firmenich AG Strategy Report
- Understand DSM-Firmenich AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
DSM-Firmenich AG (DSM-Firmenich) is a science-based company with focus on identifying environmental, social challenges and opportunities, then it captures such opportunities to create long-term positive impact on people and planet, finally it focuses on building growth through long-term, performance driven profitable growth. The company produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resin solutions. The company develops materials for medical devices and clean energy from crop residues and bio-chemicals. The company’s businesses are closely aligned with its customers to facilitate rapid. development of impactful science-bases innovations. The company has operations in Eastern Europe, Latin America, North America, Asia Pacific and other regions. DSM-Firmenich is headquartered in Kaiseraugst, Switzerland.
DSM-Firmenich AG premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
ABS Polymer | Custom Manufacturing Services | AgiSyn |
Active Ingredients | Akulon | |
Additives | ALPAFLOR | |
XYZ | XYZ | |
XYZ | XYZ | |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Divestiture | In March, the company sold DSM Jiangshan Pharmaceutical to Jingjiang Cosfocus Health Technology Co., Ltd. |
2024 | Contracts/Agreements | In February, the company entered into a partnership with Zerion Pharma to enhance the bioavailability of cannabinoids. |
2023 | Regulatory Approval | In December, the company received market authorization for Bovaer in the UK. |
Competitor Comparison
Key Parameters | DSM-Firmenich AG | BASF SE | Solvay SA | Akzo Nobel NV | Novozymes AS |
---|---|---|---|---|---|
Headquarters | Switzerland | Germany | Belgium | Netherlands | Denmark |
City | Kaiseraugst | Ludwigshafen Am Rhein | Bruxelles | Amsterdam | Bagsvaerd |
State/Province | - | Rheinland-Pfalz | Bruxelles-Capitale | - | - |
No. of Employees | - | 111,991 | 22,000 | 35,200 | 6,397 |
Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Geraldine Matchett | Chief Financial Officer; Co-Chief Executive Officer | Senior Management | 2020 | 51 |
Dimitri de Vreeze | Co-Chief Executive Officer; Chief Operating Officer | Senior Management | 2021 | 56 |
Katharina Stenholm | Chief Sustainability Officer | Senior Management | 2023 | - |
Patricia Malarkey | Chief Innovation Officer | Senior Management | 2019 | - |
Thomas Leysen | Chairman | Non Executive Board | 2021 | 63 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward